Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...

Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ...

Maybank Securities’ Thilan Wickramasinghe hiked his target price to $14.16 from $10.12, but RHB Bank Singapore’s Shekhar ...

Razorpay co-founder and CEO Harshil Mathur talks about the company’s 10-year journey, the upcoming IPO and buying his first suit at the advice of Sam Altman ...

Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted ...

The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an analysis here.

The exchange maintained its position as the second-largest bourse in the region and reinforced its ranking among the world's ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...

SAO PAULO (Reuters) -Brazilian chemical firm Unigel said on Thursday it had no plans to launch an initial public offering in the short term, after newspaper Valor Economico reported that Unigel could ...

Hexaware, majority owned by private equity firm Carlyle Group, has filed revised papers to launch a ₹8,750 crore IPO, lower ...

The promoter initially planned to raise $1.2 billion when it had filed for regulatory approval in September. The size of ...

Gemini’s reported fresh IPO plans come as crypto asset manager Bitwise predicted that at least five “crypto unicorns” would ...